The Female Health Company
OrganizationRelationship Network
Event Timeline
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
organization
UNFPA
|
Business associate |
5
|
1 | |
|
organization
Rutgers WPF
|
Business associate |
1
|
1 | |
|
person
Dr. David Holtgrave
|
Researcher subject |
1
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2009-01-01 | N/A | FC2 becomes available in the U.S. | USA | View |
| 2007-01-01 | N/A | FC2 becomes available globally | Global | View |
| 1993-01-01 | N/A | FDA approval of FC1 Female Condom | USA | View |
EFTA00036836.pdf
This document is an email forwarded on August 9, 2019—the day before Jeffrey Epstein's death—regarding mandatory NIMS crisis management training for staff at the Metropolitan Correctional Center (MCC) in New York. The original email from July 23, 2019, instructs staff to complete FEMA ICS courses and submit certificates to Lt. Rice by August 22, 2019, to maintain membership on crisis management teams. The email signature confirms the sender is a Captain at the MCC located at 150 Park Row.
DOJ-OGR-00015626.jpg
This document is a first-floor architectural plan for the 'Epstein Residence' at 358 El Brillo Way, Palm Beach, Florida, dated September 24, 1994. Created by architects Roger Wm. Sahli and Michael J. Johnson, the drawing includes extensive handwritten notes detailing proposed renovations, such as modifying the pool, updating rooms, and ensuring compliance with FEMA regulations for certain equipment.
HOUSE_OVERSIGHT_027082.jpg
A presentation slide produced by The Female Health Company outlining the benefits of female condoms, including protection against HIV and Zika, increased protected sex acts in the market, and return on investment. The document bears a House Oversight Committee Bates stamp.
HOUSE_OVERSIGHT_027078.jpg
This document is a promotional or informational slide for The Female Health Company regarding their product, the FC2 female condom. It outlines the product's benefits, including protection against HIV/AIDS, STIs (specifically mentioning Zika), and pregnancy, while noting approvals by the FDA and WHO. The document includes a footer 'HOUSE_OVERSIGHT_027078', indicating it is an exhibit within a House Oversight Committee investigation.
HOUSE_OVERSIGHT_027077.jpg
This document is a presentation slide or proposal titled 'ASK' from the House Oversight evidence files. It outlines a funding shortfall at the UNFPA caused by the US pulling funding under President Trump and European funds being redirected to migrant issues. The Female Health Company is explicitly soliciting donors to fill this gap by donating to UNFPA with funds earmarked specifically for the purchase of FC2 female condoms for ten specific developing nations.
HOUSE_OVERSIGHT_027076.jpg
This document appears to be a slide or screenshot from a presentation featuring promotional material for FC2 (The Female Health Company). It displays a YouTube video embed titled 'Empowering Kenya' and links to the company's website (femalecondom.com). The document bears a House Oversight Committee Bates stamp (027076), indicating it was part of the document production for the investigation, likely related to financial or business records involving the company.
HOUSE_OVERSIGHT_027075.jpg
A presentation slide titled 'Overview' from The Female Health Company (FC2). The slide features a photograph of three women and lists agenda items such as 'Commodity Context' and 'Debunking myths through evidence.' It bears a House Oversight Bates stamp number 027075.
HOUSE_OVERSIGHT_027074.jpg
This document appears to be a cover page for a presentation or brochure produced by The Female Health Company regarding the 'FC2 Female Condom.' It features imagery of the product and slogans related to HIV prevention and health rights. It bears a House Oversight Committee document stamp (027074) at the bottom right, indicating it was part of an investigation file.
HOUSE_OVERSIGHT_027072.jpg
This document is a proposal from the Female Health Company (FHC) seeking partnership and funding from new donors to supply FC2 female condoms to African nations (specifically Uganda, Kenya, and Zimbabwe) to combat HIV/AIDS. It highlights a funding gap, offers branding opportunities for donors, and cites economic effectiveness studies by Dr. David Holtgrave of Johns Hopkins to justify the investment. The document appears to be part of a larger House Oversight investigation file (HOUSE_OVERSIGHT_027072), likely related to solicitations made to the Epstein Foundation or related entities.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity